Erasca, Inc. (ERAS) Misses Q2 EPS by 11c

Erasca, Inc. (NASDAQ: ERAS) reported Q2 EPS of ($0.29), $0.11 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Erasca, Inc. (ERAS) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Samsung Plans As Much As $79 Billion In Shareholder Returns - Bloomberg
• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic